Seed Health and the Swiss Institute of Allergy and Asthma Research Launch Novel Immunology Platform to Develop the Next Generation of Microbiome and Barrier-Safe Personal Care Products

Combining microbiome science and epithelial immunology, the platform powers a multi-category innovation pipeline LOS ANGELES and DAVOS, Switzerland, Jan. 18, 2023 /PRNewswire/ -- Seed Health, a microbiome science company, and the Swiss Institute of Allergy and Asthma Research (SIAF) today...

Click to view original post